Single Blinded Randomized Trial of Transversus Abdominis Plane Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
Latest Information Update: 29 Nov 2024
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 26 Nov 2024 Status changed from recruiting to completed.
- 28 Nov 2023 Planned End Date changed from 1 Feb 2024 to 1 Feb 2025.
- 28 Nov 2023 Planned primary completion date changed from 1 Nov 2023 to 1 Nov 2024.